Bilateral progressive orbital myositis as immune-related adverse event of pembrolizumab
Can J Ophthalmol
.
2024 Mar 8:S0008-4182(24)00040-1.
doi: 10.1016/j.jcjo.2024.02.007.
Online ahead of print.
Authors
Isana Nakajima
1
,
Tomoko Nakaizumi
2
,
Hideki Tsuji
2
Affiliations
1
Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic address: jm-i-nakajima@kochi-u.ac.jp.
2
Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
PMID:
38462232
DOI:
10.1016/j.jcjo.2024.02.007
No abstract available